链霉菌H03发酵液提取物的抗菌活性研究

以常见的病原细菌和植物病原真菌为指示菌研究了链霉菌发酵液提取物的抗菌活性,测定了发酵液提取物的抗菌谱和最小抑菌浓度(MIC)。结果表明:与青霉素、链霉素相比,该菌发酵液提取物的抗菌范围更广,对植物病原真菌棉花黄萎病菌、苹果轮纹病菌、小麦赤霉病菌、油菜菌核病菌、黄瓜炭疽病菌、甜菜褐斑病菌、稻瘟病菌,以及常见病原细菌大肠杆菌、枯草杆菌、绿脓杆菌和金黄色葡萄球菌都具有明显的抑制作用。利用试管二倍稀释法测定发酵液提取物对上述诸菌的最小抑菌浓度(MIC),结果分别为0.125、0.062 5、0.125、0.25、0.015、0.03、0.015、0.015、0.03、0.250、.015 mg/mL。其中对植物病原真菌中的黄瓜炭疽病菌、甜菜褐斑病菌、稻瘟病菌,以及病原细菌中的大肠杆菌、枯草杆菌、金黄色葡萄球菌抑制效果最佳。将发酵液提取物置于100℃下加热处理10 min后,其对金黄色葡萄球菌的抑菌活性不变,说明该发酵液提取物具有较好的热稳定性。     

天然海鱼共附生放线菌抑菌和抗病毒活性筛选研究

从台湾海峡天然海鱼共附生微生物群落分离得到29株放线菌,通过抗病毒和抑菌活性筛选,分别得到6株对烟草花叶病毒和植物病原真菌具有较强抑制作用的天然菌株.其中,菌株030603对供试植物病原真菌拮抗作用尤为显著,其发酵产物具有广谱抑菌活性,可以作为广谱性植物病原真菌拮抗菌株进行生防菌产业化开发及发酵产物活性成分的化学研究.该菌株形态特征、培养特性、生理生化特性与微白黄链霉菌基本一致,16 S rDNA序列同源性达99.5 %.实验结果表明,利用天然海洋鱼类共附生微生物群落获取植物病原菌拮抗菌株具有取样便捷和活性菌株检出率高的特点.     

骆驼蓬内生真菌抑菌活性的研究

以金黄色葡萄球菌、大肠杆菌、鼠伤沙门氏菌及大肠杆菌F为测试菌种,对从骆驼蓬(Peganum harmala L.)叶中分离出的14株内生真菌及其次生代谢产物进行了抗菌活性筛选。结果表明:8个菌株及10个菌株的代谢产物均至少对1种试验细菌具有抑菌活性,其中1株内生真菌及其次生代谢产物对测试病原细菌具有较强的抑菌作用。     

膜荚黄芪内生真菌次生代谢产物鉴定及抑菌活性

从膜荚黄芪(Astragalus membranaceus)叶中分离出一株内生真菌———瓶霉菌属(Phialophorasp.)。鉴定次生代谢产物中含有皂甙类、多糖类和黄酮类物质,并通过薄层层析证明内生真菌次生代谢产物的粗提物与黄芪植物水煎液的粗提物含有相同的成分。证明发酵液及菌丝体提取物对4种常见细菌具有不同程度的抑菌活性。     

10种药用植物乙醇提取物的抑真菌活性研究

真菌病害是降低农作物产量和品质的最重要因素之一,严重威胁粮食安全.化学农药是防治真菌的有效手段,但长期不合理的使用,其弊端凸显;而采用植物代谢产物防治真菌病害是化学杀菌剂的理想替代品.因此,本研究采用菌丝生长速率法,检测了10种药用植物的乙醇提取物对9种植物病原真菌的抑制效果.结果表明姜黄、川芎、苦参乙醇提取物在1 000 g/mL浓度下对超过5种真菌(马铃薯晚疫菌、西瓜枯萎菌、小麦赤霉菌、水稻纹枯菌和苹果轮纹菌)的抑制率高于50%,显示出较高的抑菌活性.本研究发现姜黄、川芎、苦参具有广谱抑菌活性,抑菌活性成分值得进一步分离鉴定,为寻找天然产物抑真菌活性物质提供了参考依据.     

放线菌G1-8菌株发酵液抗菌谱及稳定性的研究

目的：研究土壤放线菌G1-8次生代谢产物的抗菌谱及其发酵液的稳定性。方法：采用抑制菌丝生长速率法、管碟法测定发酵液的生物活性。在不同条件下测定发酵液的稳定性。结果：在对12种供试病原真菌的抑制效果中,6种达到80％以上。在连续传代10代过程中,4℃及常温条件保存下,培养特征和抑菌活性基本没有变化。发酵液在60．100℃的温度梯度下没有丧失活性,在pH2和12的强酸、碱条件下也都比较稳定。结论：该菌株的代谢产物具有广谱抗菌活性和很强稳定性,具有一定开发价值。     

杜仲内生真菌的抑菌活性筛选

以金黄色葡萄球菌、枯草芽孢杆菌、大肠杆菌为测试菌种。对杜仲(Eucommia ulmoides Oliv.)根、茎、叶中分离出的20株内生真菌及其次生代谢物进行抗菌活性筛选。结果表明：有15个菌株至少对1种实验细菌具有抑菌活性,19株的代谢产物至少对1种实验细菌具有抑菌活性,其中有3株内生真菌及其次生代谢产物对测试病原细菌均有较强抑制作用。     

黄麻链霉菌AUH-1发酵液的抗菌活性及其稳定性研究

旨在研究黄麻链霉菌AUH-1菌株发酵液的抗真菌活性,并明确温度、紫外线及pH等理化因素对活性物质稳定性的影响。以8种植物病原真菌为供试菌,采用抑制菌丝生长速率法测定发酵液的抗真菌活性,并以水稻纹枯病菌为指示菌,测定不同条件下发酵液的抑菌活性。抗真菌活性结果表明:AUH-1菌株发酵液对8种植物病原真菌均具有不同程度的抑制作用,其中对西瓜枯萎病菌、烟草黑胫病菌、水稻纹枯病菌以及辣椒疫病菌的抑制效率分别高达81%、78%、68%和67%以上。稳定性实验结果表明:AUH-1菌株所产抗真菌活性物质具有良好的热稳定性和紫外稳定性。可见,黄麻链霉菌AUH-1具有广谱拮抗作用,具备开发生物农药的良好应用前景。     

绿粘帚霉菌株发酵液抗真菌活性及稳定性测定

采用杯碟法测定绿粘帚霉（RCEF4099）菌株的发酵液对8种植物病原真菌的抗菌活性。结果表明RCEF4099菌株发酵液对5种供试病原真菌的抑菌圈直径在18mm以上。对菌株发酵液的稳定性测定结果表明菌株转接6代之前,活性稳定,从第7代开始其活性缓慢降低,第10代的抑菌圈直径仅比出发菌株减少了1．7mm。RCEF4099菌株发酵液有较好的热稳定性,发酵液加热到60％仍有较高活性。该菌株的发酵液对酸的稳定性较好,抑菌活性最强的pH值为4。     

陕北野生甘草内生菌的分离及抑菌活性筛选

采用组织块分离法从陕北野生甘草根中分离出21株内生菌,其中细菌12株,真菌6株,放线菌3株.为明确内生菌代谢产物的抑菌活性,采用抑制菌丝生长速率法和组织测定法系统测定了其发酵液对植物病原真菌的抑制作用.结果表明,在离体条件下,甘草内生菌发酵液对供试的7种植物病原菌菌丝生长均有一定的抑制作用,其中Z4和F1菌株的发酵液对供试病原菌菌丝生长的抑制作用较强,特别是对苹果干腐病菌和烟草赤星病菌的抑制作用最强,抑制率分别可达92.36%、90.16%和91.20%、90.43%,EC50分别仅为54.38、90.31和57.50、89.58 mg·L-1;组织法测定中,发酵液稀释10倍后,Z4和F1菌株对苹果干腐病的保护作用分别为75.39%和73.13%,治疗效果分别为67.61%和60.75%.     

中国金孢属一新记录种

Fermentation broth of endophytic fungus Trichoderma taxi ZJUF0986 has high antifungal activity to the common 15 species of phytopathogenic fungi. Three bioactive metabolites I, II and III were obtained by extracted with petroleum ether, ethyl acetate and n-butanol and subsequent silica gel column chromatography and preparative HPLC. Among them, compound I, the main metabolite, has strong broad-spectrum antifungal activity, especially to Botrytis cinerea, Rhizoctonia solani and Sclerotinia sclerotiorum with IC50 1.06, 1.08 and 1.13 mg/L, respectively.     

中国金孢属一新记录种

金孢属Chrysosporium是Corda于1833年以革质金孢C. corii Corda为模式种建立的一类有丝分裂产孢真菌.它的有性型主要隶属爪甲团囊菌目Onygenales中的爪甲团囊菌科Onygenaceae和裸囊菌科Arthrodermataceae(Kirk et al.2001;Oorschot 1980).此属真菌大多能分解角蛋白,极有应用价值.     

洋葱伯克霍尔德菌CF_66抗菌物质的分离纯化及性质的研究

洋葱伯克霍尔德菌CF-66能够抑制立枯丝核菌等若干植物病原菌和其它一些真菌的生长。CF-66菌发酵液的粗提液通过Sephadex-75pg、Sephacryl S-100柱层析分离纯化,获得抗菌物质CF66I。此抗菌物质耐热性强,耐碱,但在强酸性条件下不稳定。低浓度有机溶剂的存在有利于抑菌活性的提高。对其结构的研究表明CF66I是以(CH2CH2O)n为主要单元结构并带有酰氨键的化合物。     

Alkaline protease inhibitor: a novel class of antifungal proteins against phytopathogenic fungi.

A Streptomyces sp., which produces an alkaline protease inhibitor (API) exhibiting antifungal activity has been isolated from soil. The protein has been purified to homogeneity. The molecular characterization has revealed that it is a dimer (M(r) 28 kDa) with five disulphide linkages and has a pI of 3.8. API is a competitive type of inhibitor with a K(i) value of 2.5 x 10(-9) M. The inhibitor is stable over a pH range of 6 to 12 and a temperature range of 40 to 95 degrees C. API exhibits antifungal activity (in vitro) against phytopathogenic fungi such as Fusarium, Alternaria, and Rhizoctonia and also against Trichoderma, a saprophytic fungus. The antifungal activity of API appears to be associated with its ability to inhibit the fungal serine alkaline protease(s), which is indispensable for its growth. Retardation of the rate of fungal spore germination, as well as hyphal extention, was observed in the presence of API. Both the protease inhibitory and the antifungal activity were abolished on treatment of API with DTT (5 mM), suggestive of a common site for both the activities. This is the first report on API as a potential biocontrol agent against phytopathogenic fungi.     

Expression and functional analysis of two osmotin (PR5) isoforms with differential antifungal activity from Piper colubrinum: prediction of structure-function relationship by bioinformatics approach

Osmotin, a pathogenesis-related antifungal protein, is relevant in induced plant immunity and belongs to the thaumatin-like group of proteins (TLPs). This article describes comparative structural and functional analysis of the two osmotin isoforms cloned from Phytophthora-resistant wild Piper colubrinum. The two isoforms differ mainly by an internal deletion of 50 amino acid residues which separates them into two size categories (16.4 kDa-PcOSM1 and 21.5 kDa-PcOSM2) with pI values 5.6 and 8.3, respectively. Recombinant proteins were expressed in E. coli and antifungal activity assays of the purified proteins demonstrated significant inhibitory activity of the larger osmotin isoform (PcOSM2) on Phytophthora capsici and Fusarium oxysporum, and a markedly reduced antifungal potential of the smaller isoform (PcOSM1). Homology modelling of the proteins indicated structural alterations in their three-dimensional architecture. Tertiary structure of PcOSM2 conformed to the known structure of osmotin, with domain I comprising of 12 β-sheets, an α-helical domain II and a domain III composed of 2 β-sheets. PcOSM1 (smaller isoform) exhibited a distorted, indistinguishable domain III and loss of 4 β-sheets in domain I. Interestingly, an interdomain acidic cleft between domains I and II, containing an optimally placed endoglucanase catalytic pair composed of Glu-Asp residues, which is characteristic of antifungal PR5 proteins, was present in both isoforms. It is well accepted that the presence of an acidic cleft correlates with antifungal activity due to the presence of endoglucanase catalytic property, and hence the present observation of significantly reduced antifungal capacity of PcOSM1 despite the presence of a strong acidic cleft, is suggestive of the possible roles played by other structural features like domain I or/and III, in deciding the antifungal potential of osmotin.     

Combinatorial approach to lead optimization of a novel hexapeptide with antifungal activity

Three sets of sublibraries of an antifungal lead peptide His-D-Trp-D-Phe-Phe-D-Phe-Lys-NH2 (I) have been prepared by introducing variations at positions 1, 4 and 6. They were screened for their antifungal activity against C. albicans and C. neoformans in order to quantify inhibition at each step of the hexapeptide sublibrary iteration. The studies led to the identification of Arg-D-Trp-D-Phe-Ile-D-Phe-His-NH2 as a novel hexapeptide with potent antifungal activity against both C. albicans and C. neoformans.     

Identification of novel antifungal nonapeptides through the screening of combinatorial peptide libraries based on a hexapeptide motif

Four sets of mixture based nonapeptide libraries derived from an antifungal hexapeptide pharmacophore Arg-D-Trp-D-Phe-Ile-D-Phe-His-NH(2) (II) have been synthesized. The three C-terminal positions 7, 8 and 9 were subject to randomization using 19 genetically coded amino acids. They were then screened for their antifungal activity against Candida albicans and Cryptococcus neoformans in order to quantify inhibition at each step of the nonapeptide sublibrary deconvolution. The studies led to the identification of several novel nonapeptides with potent antifungal activity. Two of the nonapeptides exhibited approximately 17-fold increase in the activity in comparison to the lead hexapeptide motif His-D-Trp-D-Phe-Phe-D-Phe-Lys-NH(2) (I) against C. albicans.     

Crystal structure of tobacco PR-5d protein at 1.8 A resolution reveals a conserved acidic cleft structure in antifungal thaumatin-like proteins

The crystal structure of tobacco PR-5d, an antifungal thaumatin-like protein isolated from cultured tobacco cells, was determined at the resolution of 1.8 A. The structure consists of 208 amino acid residues and 89 water molecules with a crystallographic R-factor of 0.169. The model has good stereochemistry, with respective root-mean-square deviations from the ideal values for bond and angle distances of 0.007 A and 1.542 degrees. Of the homologous PR-5 proteins, only those with antifungal activity had a common motif, a negatively charged surface cleft. This cleft is at the boundary between domains I and II, with a bottom part consisting of a three-stranded antiparallel beta-sheet in domain I. The acidic residues located in the hollow of the cleft form the beta-sheet region. Sequence and secondary structure analyses showed that the amino acid residues comprising the acidic cleft of PR-5d are conserved among other antifungal PR-5 proteins. This is the first report on the high-resolution crystal structure of an antifungal PR-5 protein. This structure provides insight into the function of pathogenesis-related proteins.     

Development of a plasma high-performance liquid chromatographic assay for LY303366, a lipopeptide antifungal agent, and its application in a dog pharmacokinetic study

An HPLC assay for plasma analysis of LY303366 (I), a semi-synthetic lipopeptide antifungal related to echinocandin B (ECB), was developed to support the selection and subsequent preclinical development of I. The method involved extraction of I from plasma with the aid of solid-phase extraction (SPE) cartidges followed by reversed-phase HPLC with UV detection at 300 nm. The method is simple, selective and is applicable to dog, rat, mouse and rabbit plasma. Validation studies using dog plasma showed that the values obtained for parameters of linearity, precision and accuracy were within acceptable limits. Based on analysis of 0.3 ml of plasma, the lower limit of quantitation was 20 ng/ml. The method has been successfully applied to determine the pharmacokinetic parameters of I in the dog following intravenous (i.v.) and oral administration. Compared to first generation ECB antifungal agents, the results of the i.v. dog study indicated a 50% reduction in clearance of the drug from plasma (0.1 l/h/kg) and an 18-fold increase in the volume of distribution at steady state (1.8 l/kg). When administered orally, compound I had an absolute bioavailability of 9%; however, plasma levels remained above the MIC for C. albicans (0.005 μg/ml) through 48 h. Given the excellent potency of I and its broad spectrum of activity relative to first generation ECB antifungal agents, the assay results for I indicate the potential for its use as a broad spectrum i.v. and oral antifungal agent.     

Characterization and antifungal activity of gazyumaru (Ficus microcarpa) latex chitinases: both the chitin-binding and the antifungal activities of class I chitinase are reinforced with increasing ionic strength

Three chitinases, designated gazyumaru latex chitinase (GLx Chi)-A, -B, and -C, were purified from the latex of gazyumaru (Ficus microcarpa). GLx Chi-A,-B, and -C are an acidic class III (33 kDa, pI 4.0), a basic class I (32 kDa, pI 9.3), and a basic class II chitinase (27 kDa, pI > 10) respectively. GLx Chi-A did not exhibit any antifungal activity. At low ionic strength, GLx Chi-C exhibited strong antifungal activity, to a similar extent as GLx Chi-B. The antifungal activity of GLx Chi-C became weaker with increasing ionic strength, whereas that of GLx Chi-B became slightly stronger. GLx Chi-B and -C bound to the fungal cell-walls at low ionic strength, and then GLx Chi-C was dissociated from them by an escalation of ionic strength, but this was not the case for GLx Chi-B. The chitin-binding activity of GLx Chi-B was enhanced by increasing ionic strength. These results suggest that the chitin-binding domain of basic class I chitinase binds to the chitin in fungal cell walls by hydrophobic interaction and assists the antifungal action of the chitinase.